Skip to main content
SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ: SWTX · IEX Real-Time Price · USD
37.72
+1.26 (3.46%)
At close: Jul 19, 2024, 4:00 PM
37.76
+0.04 (0.11%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

SpringWorks Therapeutics Revenue

SpringWorks Therapeutics had revenue of $26.45M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $21.01M. In the year 2023, SpringWorks Therapeutics had annual revenue of $5.45M.

Revenue (ttm)
$26.45M
Revenue Growth
n/a
P/S Ratio
105.64
Revenue / Employee
$116,533
Employees
227
Market Cap
2.79B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.45M--
Dec 31, 20220--
Dec 31, 20210--
Dec 31, 202035.00M--
Dec 31, 20190--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 8.97B
agilon health 4.78B
Progyny 1.11B
Tandem Diabetes Care 770.01M
MorphoSys AG 264.75M
Agios Pharmaceuticals 29.40M
Geron 520.00K
Revenue Rankings

SWTX News

More News